Invitae launches multi-site study to evaluate the role of testing guidelines in ensuring access to genetic information for men with prostate cancer
Base Genomics announces company launch and raises $11 million USD to commercialize epigenetic technology for early and sensitive detection of cancer from liquid biopsy